Exports to Arab countries rise 19%

Israel's exports to Arab countries grew to $206 million in the first nine months of 2006, 19 percent more than the parallel period last year, the Israel Exports Institute said Sunday.

By AVI KRAWITZ
December 4, 2006 08:29

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israel's exports to Arab countries grew to $206 million in the first nine months of 2006, 19 percent more than the parallel period last year, the Israel Exports Institute said Sunday. Sales to Egypt led the growth, 36% higher than last year at $92m. influenced mainly by the QIZ agreement signed between the two countries in February 2005 under which Egyptian companies can export to the US tax-free, provided that 35% of the product is jointly Egyptian and Israeli, and that the Israeli component constitutes at least 11.7%. Exports to Jordan rose 12.5% to 496m. even as the number of exporters operating there has dropped 25% to 1,300 since 2004.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS